Trial Profile
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 (Randomised Controlled Phase II Clinical Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2024
Price :
$35
*
At a glance
- Drugs Trafermin (Primary)
- Indications Periodontitis
- Focus Therapeutic Use
- Sponsors Kaken Pharmaceutical
- 17 Jun 2014 New trial record